If your goal is to lose 15 pounds with a GLP-1 medication, the next step is getting evaluated by a licensed provider
For review articles in particular, explicit articulation of decision criteria strengthens credibility by demonstrating that inclusion reflects systematic reasoning rather than narrative convenience
Caution should be used in patients with long-standing diabetes with neuropathy and gastroparesis, as well as incompletely treated diabetic retinopathy
Clinical data[ 6] show that these effects are typically mild to moderate and tend to diminish with continued treatment
It allows researchers to investigate receptor cross-talk, hormonal signaling cascades, and downstream effects on metabolic outcomes in preclinical models
[8] [9] [10] [11] Although reduced GLP-1 secretion has previously been associated with attenuated incretin effect in patients with type 2 diabetes, further research indicates that GLP-1 secretion in patients with type 2 diabetes does not differ from healthy subjects